Moreover, we showed for the first time to the best of our knowledge, that MALAT1 oncogenic activity in HCC is mediated by direct interaction with β-catenin and activation of the Wnt/β-catenin signaling pathway (Figure 3 and Figure 4). Here, MALAT1 is linked to hepatocellular carcinoma.